Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting
Consult a doctor if side effects last or worsen
How to read preclinical evidence without over-reading it Preclinical does not mean worthless it means early
Many patients achieve their target weight
US$ 25.65
US$ 22.38
US$ 22.27
US$ 20.91
US$ 23.19
